Mark Greener

1000 total citations
212 papers, 681 citations indexed

About

Mark Greener is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Mark Greener has authored 212 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 25 papers in Pediatrics, Perinatology and Child Health and 23 papers in Epidemiology. Recurrent topics in Mark Greener's work include Pharmaceutical studies and practices (13 papers), Asthma and respiratory diseases (12 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Mark Greener is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Asthma and respiratory diseases (12 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Mark Greener collaborates with scholars based in United Kingdom, Canada and Spain. Mark Greener's co-authors include Julian F. Guest, Roland G. Roberts, Francis Ruiz, I F Trotman, Gary D. Monheit, Andy Pickett, Jeffrey S. Dover, Peter Vowden, Kathryn Vowden and Michael Feher and has published in prestigious journals such as FEBS Letters, EMBO Reports and Pest Management Science.

In The Last Decade

Mark Greener

143 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Greener United Kingdom	11	125	121	72	70	60	212	681
Jennifer MacKenzie Canada	16	246 2.0×	142 1.2×	35 0.5×	57 0.8×	94 1.6×	55	1.0k
Brian Hutchinson United States	14	84 0.7×	100 0.8×	41 0.6×	29 0.4×	91 1.5×	40	686
Michael Ntim China	15	177 1.4×	60 0.5×	86 1.2×	42 0.6×	44 0.7×	31	654
Μάρκος Σγάντζος Greece	15	112 0.9×	62 0.5×	108 1.5×	23 0.3×	50 0.8×	96	709
Karen Birmingham United Kingdom	16	175 1.4×	126 1.0×	65 0.9×	23 0.3×	119 2.0×	102	1.1k
Mayumi Tsuji Japan	16	66 0.5×	89 0.7×	45 0.6×	37 0.5×	89 1.5×	88	742
Yvonne Jansen Netherlands	14	118 0.9×	68 0.6×	33 0.5×	45 0.6×	97 1.6×	27	885
Margaret Moore Ireland	6	40 0.3×	121 1.0×	29 0.4×	39 0.6×	61 1.0×	10	618
Xuemei Han China	14	287 2.3×	99 0.8×	48 0.7×	14 0.2×	52 0.9×	32	786

Countries citing papers authored by Mark Greener

Since Specialization

Citations

This map shows the geographic impact of Mark Greener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Greener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Greener more than expected).

Fields of papers citing papers by Mark Greener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Greener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Greener. The network helps show where Mark Greener may publish in the future.

Co-authorship network of co-authors of Mark Greener

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Greener. A scholar is included among the top collaborators of Mark Greener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Greener. Mark Greener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Greener, Mark. (2024). Breast cancer-related lymphoedema: advances and outstanding issues. British Journal of Community Nursing. 29(Sup10). S26–S28. 1 indexed citations

2.

Greener, Mark. (2023). Is the NHS ready for new Alzheimer's disease treatments?. Prescriber. 34(7). 15–18. 1 indexed citations

3.

Greener, Mark. (2023). Understanding obesity. Independent Nurse. 2023(10). 10–12.

4.

Greener, Mark. (2023). mRNA anti‐cancer vaccine research gains momentum. Prescriber. 34(3). 5–8. 1 indexed citations

5.

Greener, Mark. (2020). Latest clinical research. Independent Nurse. 2020(9). 13–14. 2 indexed citations

6.

Greener, Mark. (2017). Latest clinical research. Independent Nurse. 2017(9). 12–13. 2 indexed citations

7.

Greener, Mark. (2017). Research roundup: February 2017. Nurse Prescribing. 15(2). 60–61.

8.

Greener, Mark. (2017). For everything there is a season: biological rhythms in psychiatry. Progress in Neurology and Psychiatry. 21(4). 30–32. 2 indexed citations

9.

Greener, Mark. (2017). Research roundup: March 2017. Nurse Prescribing. 15(3). 112–113.

10.

Greener, Mark. (2015). Curbing the winter killer. Independent Nurse. 2015(18). 18–18.

11.

Greener, Mark. (2015). Co‐commissioning: the architecture of integration. Practical Diabetes. 32(1). 10–10. 2 indexed citations

12.

Feher, Michael, et al.. (2013). Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. 6. 11–11. 20 indexed citations

13.

Greener, Mark. (2013). Nurses may lack insulin knowledge. Nurse Prescribing. 11(6). 270–270. 1 indexed citations

14.

Greener, Mark. (2011). Easing the burden of COPD. Independent Nurse. 2011(4). 1 indexed citations

15.

Guest, Julian F., et al.. (2005). Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Primary Care Respiratory Journal. 14(2). 88–98. 52 indexed citations

16.

Guest, Julian F., et al.. (2005). A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK. Current Medical Research and Opinion. 21(2). 271–280. 6 indexed citations

17.

Hulton, Sally‐Anne & Mark Greener. (2004). Increasing the use of orphan drugs in clinical practice. Hospital Medicine. 65(7). 400–403. 4 indexed citations

18.

Greener, Mark. (2004). Beware the precautionary principle?. British Journal of Healthcare Management. 10(6). 174–177. 3 indexed citations

19.

Greener, Mark & Roland G. Roberts. (2000). Conservation of components of the dystrophin complex in Drosophila¹. FEBS Letters. 482(1-2). 13–18. 77 indexed citations

20.

Greener, Mark. (1999). Counting the cost of Alzheimer??s disease. Inpharma Weekly. &NA;(1180). 5–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact